ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,803Medicare Part D Prescriptions Filled, Including Refills

Rank: 247 out of 1278

$229K Total Retail Price of All Prescriptions

Rank: 500 out of 1278

478 Patients Receiving at Least One Drug in Part D
54%Patients 65 Years and Older
70% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arizona
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 478 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

17% of this provider’s 478 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

3% of this provider’s 3,616 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

16% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$34 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

14 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arizona
LISINOPRIL 556 274 1 1
SIMVASTATIN 364 174 2 3
OMEPRAZOLE 305 138 3 6
METFORMIN HCL 295 164 4 4
LEVOTHYROXINE SODIUM 255 103 5 2
HYDROCHLOROTHIAZIDE 189 123 6 8
GABAPENTIN 175 53 7 12
HYDROCODONE-ACETAMINOPHEN 174 64 S3 8 7
AMLODIPINE BESYLATE 160 98 9 5
METOPROLOL TARTRATE 131 86 10 9
LOVASTATIN 126 52 11 13
DICLOFENAC SODIUM 103 43 12 74
TRAZODONE HCL 102 74 13 38
NAPROXEN 100 55 14 70
ATENOLOL 99 65 15 11
CITALOPRAM HBR 93 50 16 22
LANTUS 89 29 17 33
FUROSEMIDE 88 27 18 10
GLIPIZIDE 87 60 19 35
RANITIDINE HCL 80 33 20 20
AZITHROMYCIN 79 41 21 37
ALENDRONATE SODIUM 71 42 22 18
TAMSULOSIN HCL 70 58 23 32
POTASSIUM CHLORIDE 70 40 23 21
GLYBURIDE 67 37 R 25 40
IBUPROFEN 66 22 26 46
OXYCODONE-ACETAMINOPHEN 64 41 S2 27 29
PRAVASTATIN SODIUM 64 51 27 14
OXYBUTYNIN CHLORIDE 61 41 29 80
PROAIR HFA 60 24 30 26
LISINOPRIL-HYDROCHLOROTHIAZIDE 55 38 31 30
CLOPIDOGREL 54 36 32 45
INSULIN SYRINGE 54 26 32 50
FENOFIBRATE 53 19 34 47
CARVEDILOL 52 37 35 39
WARFARIN SODIUM 52 52 35 17
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 17, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.